If the advisory panel endorses the shot and the FDA agrees, it would become the second option for those children, joining Pfizer’s vaccine.
vaccine
Posted inHealth, Nation & World
FDA advisers back Novavax COVID-19 shots as new U.S. option
Studies in the U.S., Mexico and Britain found two doses of the vaccine were safe and about 90% effective.
advertisement
Posted inHealth, Nation & World, News
First COVID vaccine shots for kids under 5 possible by June 21
White House COVID-19 coordinator Aashish Jha outlined the administration’s planning for the last remaining ineligible age group to get shots.
Posted inNation & World, News
Biden receives second booster, presses Congress on virus funds
The president used the occasion Wednesday to call on Congress to pass billions of dollars in additional funding to fight the pandemic.
Posted inNation & World, News
FDA authorizes another booster shot of Pfizer or Moderna vaccine for people 50 and older
The question is whether everyone who’s eligible should rush out and get it.
Posted inHealth, Nation & World, News
COVID-19 shots found unlikely to prompt inflammation in children
A new analysis shows that vaccines are unlikely to trigger multisystem inflammatory syndrome, a rare complication in kids who have had COVID-19.
Posted inOp-Eds, Opinion
The Maine Millennial: Some were saved from the Holocaust with vaccines
Among the medicines that anti-vaxxers compare to Nazi war crimes were those developed by prisoners and enemies of the Third Reich.
Posted inNation & World
Step by step, more nations ease coronavirus restrictions
The loosening of omicron’s grip in many places has given rise to hope that the outbreak is about to enter a new phase in which the virus will become, like the flu, a persistent but generally manageable threat that people can live with.
Posted inHealth, Local & State, News
Maine CDC ending contact tracing for COVID-19 during omicron wave
COVID-19 hospitalizations decreased again Wednesday and are down 21% since the January peak.
Posted inHealth, Nation & World, News
Pfizer vaccine for children younger than 5 could be available by end of February
Pfizer and its partner, BioNTech, are expected to submit a request for emergency use authorization to the Food and Drug Administration as early as Tuesday.